Flavacridine for gonorrhoid arthritis

Cover Page

Cite item

Full Text

Abstract

The tempting idea of ​​chemotherapy for urinary infections has attracted understandable attention of urologists over the past decade. Among the various chemotherapy drugs, much attention has been paid to trypoflavin (gonacrine) for gonorrhea and its complications. Barbellion provides the following theoretical justifications for the use of chemicals (triggoflavin, gotsacrine). The introduction of the drug into the body provides: 1) complete and rapid impregnation of the entire body through the hemotogenic system; 2) long-term permanent impregnation of the body as opposed to short-term local therapy; 3) the constant presence of the drug in the urine makes it bactericidal, antiseptic and allows you to disinfect the entire urogenital tract; 4) the simplicity and unity of the treatment method with all possible localization of the process makes it possible to discard all the other numerous methods; 5) simplification of the doctor's work, who often remains helpless in search of hidden foci of infection, the possibility of standardization, the ease of use of the drug, which allows it to be used in the most modest dispensary, facilitates the fight against gonorrhea.

About the authors

A I Dmitriev

Отдел. мужской гонореи О. Г. В. И. им. Броннера (зав. отд. проф. Р. М. Фронштейн)

Email: info@eco-vector.com
Russian Federation

I I Zdobnov

Отдел. мужской гонореи О. Г. В. И. им. Броннера (зав. отд. проф. Р. М. Фронштейн)

Email: info@eco-vector.com
Russian Federation

N M Porudominskiy

Отдел. мужской гонореи О. Г. В. И. им. Броннера (зав. отд. проф. Р. М. Фронштейн)

Author for correspondence.
Email: info@eco-vector.com
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2021 Eco-Vector





Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).